The company has already said they are restricted in what they can say. Their wont be much, if any, efficacy data.
The best we have been offered is a story about a patient (Nick ede's email i think?), which is good if shown conclusively that the imugene drug caused their improvement.
IMHO, temper expectations.
I am hoping they surprise with a bcell/HV deal out of the blue.
GLTA.
Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens, page-152
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.001(1.02%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $441.4K | 9.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 123 | 16660204 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 227233 | 7 |
View Market Depth
| Last trade - 15.43pm 21/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |